Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer

Summary

RATIONALE: Inserting the gene for p53 into a person's tumor may improve the body's ability to fight cancer or make the cancer more sensitive to chemotherapy. PURPOSE: Phase II trial to study the effectiveness of gene therapy in treating patients who have recurrent head and neck cancer.

Timeline

Start

1998-01

Primary completion

—

Completion

—

Drugs

Indications